Bromodomain Containing 4 (BRD4) (N-Term) Peptid
Kurzübersicht für Bromodomain Containing 4 (BRD4) (N-Term) Peptid (ABIN8095728)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Verwendungszweck
- BRD4 Peptide - N-terminal region
-
Sequenz
- NPPPPEYINT KKNGRLTNQL QYLQKVVLKD LWKHSFSWPF QRPVDAVKLQ
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-BRDT Antibody (ARP34016_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- BRD4 (Bromodomain Containing 4 (BRD4))
-
Hintergrund
-
Background Information: The protein encoded by this gene is homologous to the murine protein MCAP, which associates with chromosomes during mitosis, and to the human RING3 protein, a serine/threonine kinase. Each of these proteins contains two bromodomains, a conserved sequence motif which may be involved in chromatin targeting. This gene has been implicated as the chromosome 19 target of translocation t(15,19)(q13,p13.1), which defines an upper respiratory tract carcinoma in young people. Two alternatively spliced transcript variants have been described.
Alternative Symbols: CAP, MCAP, HUNK1, HUNKI
-
Molekulargewicht
- 50kDa
-
Gen-ID
- 23476
-
NCBI Accession
- NP_055114
-
UniProt
- O60885
Target
-